Aleksandra Mandic Havelka

1.2k total citations
22 papers, 909 citations indexed

About

Aleksandra Mandic Havelka is a scholar working on Molecular Biology, Epidemiology and Cell Biology. According to data from OpenAlex, Aleksandra Mandic Havelka has authored 22 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Epidemiology and 5 papers in Cell Biology. Recurrent topics in Aleksandra Mandic Havelka's work include Cell death mechanisms and regulation (8 papers), Sepsis Diagnosis and Treatment (5 papers) and Calpain Protease Function and Regulation (2 papers). Aleksandra Mandic Havelka is often cited by papers focused on Cell death mechanisms and regulation (8 papers), Sepsis Diagnosis and Treatment (5 papers) and Calpain Protease Function and Regulation (2 papers). Aleksandra Mandic Havelka collaborates with scholars based in Sweden, Portugal and Japan. Aleksandra Mandic Havelka's co-authors include Stig Linder, Maria C. Shoshan, Maria Berndtsson, Takayuki Ueno, Maria Hägg, Theocharis Panaretakis, Maria Hägg Olofsson, Stephan Schwarz, Slavica Brnjic and Anders Larsson and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Scientific Reports.

In The Last Decade

Aleksandra Mandic Havelka

19 papers receiving 893 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aleksandra Mandic Havelka Sweden 13 476 258 158 132 110 22 909
Sung‐Chul Lim South Korea 20 551 1.2× 305 1.2× 155 1.0× 118 0.9× 68 0.6× 56 1.0k
Yi‐Hsiung Lin Taiwan 19 666 1.4× 138 0.5× 150 0.9× 118 0.9× 137 1.2× 50 1.2k
Tomoko Inoue Japan 19 565 1.2× 286 1.1× 91 0.6× 175 1.3× 62 0.6× 50 1.0k
Kageaki Kuribayashi Japan 19 607 1.3× 262 1.0× 91 0.6× 184 1.4× 71 0.6× 54 1.2k
Veerle Van Marck Belgium 21 448 0.9× 150 0.6× 183 1.2× 130 1.0× 62 0.6× 45 1.1k
Li-Yuan Bai Taiwan 17 466 1.0× 150 0.6× 109 0.7× 102 0.8× 89 0.8× 42 869
Gabriella Emri Hungary 23 521 1.1× 388 1.5× 86 0.5× 219 1.7× 111 1.0× 71 1.2k
Shouyue Zhang China 20 736 1.5× 172 0.7× 245 1.6× 98 0.7× 135 1.2× 34 1.2k
Ying Zheng China 21 556 1.2× 166 0.6× 85 0.5× 152 1.2× 127 1.2× 43 1.1k
Chenglong Li China 20 668 1.4× 152 0.6× 148 0.9× 108 0.8× 79 0.7× 66 1.1k

Countries citing papers authored by Aleksandra Mandic Havelka

Since Specialization
Citations

This map shows the geographic impact of Aleksandra Mandic Havelka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleksandra Mandic Havelka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleksandra Mandic Havelka more than expected).

Fields of papers citing papers by Aleksandra Mandic Havelka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleksandra Mandic Havelka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleksandra Mandic Havelka. The network helps show where Aleksandra Mandic Havelka may publish in the future.

Co-authorship network of co-authors of Aleksandra Mandic Havelka

This figure shows the co-authorship network connecting the top 25 collaborators of Aleksandra Mandic Havelka. A scholar is included among the top collaborators of Aleksandra Mandic Havelka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleksandra Mandic Havelka. Aleksandra Mandic Havelka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Havelka, Aleksandra Mandic, et al.. (2025). B-078 Validation of the GCAL®, Gentian Calprotectin Immunoassay on the QuidelOrtho Vitros 5600 Chemistry Analyzer. Clinical Chemistry. 71(Supplement_1).
2.
Bohn, Mary Kathryn, Aleksandra Mandic Havelka, Mats Eriksson, & Khosrow Adeli. (2024). Validation of Serum Calprotectin Relative to Other Biomarkers of Infection in Febrile Infants Presenting to the Emergency Department. Antibiotics. 13(5). 425–425. 1 indexed citations
3.
4.
Havelka, Aleksandra Mandic, Anders Larsson, Johan Mårtensson, et al.. (2023). Analysis of Calprotectin as an Early Marker of Infections Is Economically Advantageous in Intensive Care-Treated Patients. Biomedicines. 11(8). 2156–2156. 6 indexed citations
5.
Nilsen, Tom, et al.. (2023). A-278 Development and Validation of Platform Independent, Turbidimetric Sars-CoV-2 Total Antibody Assay. Clinical Chemistry. 69(Supplement_1). 1 indexed citations
6.
Nilsen, Tom, et al.. (2023). A-102 Development and Validation of Turbidimetric Retinol Binding Protein (RBP) Assay. Clinical Chemistry. 69(Supplement_1). 1 indexed citations
7.
Havelka, Aleksandra Mandic, et al.. (2022). Early kinetics of calprotectin in plasma following inguinal hernia surgery. Innate Immunity. 28(1). 49–54. 6 indexed citations
8.
Havelka, Aleksandra Mandic, et al.. (2020). Calprotectin, a new biomarker for diagnosis of acute respiratory infections. Scientific Reports. 10(1). 4208–4208. 47 indexed citations
9.
Helmersson‐Karlqvist, Johanna, Mats Flodin, Aleksandra Mandic Havelka, Xiao Yan Xu, & Anders Larsson. (2016). The Roche Immunoturbidimetric Albumin Method on Cobas c 501 Gives Higher Values Than the Abbott and Roche BCP Methods When Analyzing Patient Plasma Samples. Journal of Clinical Laboratory Analysis. 30(5). 677–681. 7 indexed citations
10.
Nilsen, Tom, et al.. (2016). A novel turbidimetric immunoassay for fecal calprotectin optimized for routine chemistry analyzers. Journal of Clinical Laboratory Analysis. 31(4). e22061–e22061. 13 indexed citations
11.
Brnjic, Slavica, Maria Hägg Olofsson, Aleksandra Mandic Havelka, & Stig Linder. (2010). Chemical biology suggests a role for calcium signaling in mediating sustained JNKactivation during apoptosis. Molecular BioSystems. 6(5). 767–774. 34 indexed citations
12.
Havelka, Aleksandra Mandic, et al.. (2010). Maternal plasma level of antimicrobial peptide LL37 is a major determinant factor of neonatal plasma LL37 level. Acta Paediatrica. 99(6). 836–841. 36 indexed citations
13.
Olofsson, Maria Hägg, Aleksandra Mandic Havelka, Slavica Brnjic, Maria C. Shoshan, & Stig Linder. (2008). Charting calcium-regulated apoptosis pathways using chemical biology: role of calmodulin kinase II. SHILAP Revista de lepidopterología. 8(1). 2–2. 46 indexed citations
14.
Berndtsson, Maria, Mélanie Beaujouin, Linda Rickardson, et al.. (2008). Induction of the lysosomal apoptosis pathway by inhibitors of the ubiquitin‐proteasome system. International Journal of Cancer. 124(6). 1463–1469. 36 indexed citations
15.
Havelka, Aleksandra Mandic, Maria Berndtsson, A. Maria Olofsson, Maria C. Shoshan, & Stig Linder. (2007). Mechanisms of Action of DNA-Damaging Anticancer Drugs in Treatment of Carcinomas: Is Acute Apoptosis an “Off-Target” Effect?. Mini-Reviews in Medicinal Chemistry. 7(10). 1035–1039. 74 indexed citations
16.
Berndtsson, Maria, Maria Hägg, Theocharis Panaretakis, et al.. (2006). Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA. International Journal of Cancer. 120(1). 175–180. 186 indexed citations
17.
Kramer, Gero, et al.. (2006). Docetaxel induces apoptosis in hormone refractory prostate carcinomas during multiple treatment cycles. British Journal of Cancer. 94(11). 1592–1598. 75 indexed citations
18.
Takahashi, Akihiro, Mikael Hanson, Håkan Norell, et al.. (2005). Preferential Cell Death of CD8+ Effector Memory (CCR7−CD45RA−) T Cells by Hydrogen Peroxide-Induced Oxidative Stress. The Journal of Immunology. 174(10). 6080–6087. 92 indexed citations
19.
Berndtsson, Maria, Yoshiyuki Konishi, Azad Bonni, et al.. (2005). Phosphorylation of BAD at Ser‐128 during mitosis and paclitaxel‐induced apoptosis. FEBS Letters. 579(14). 3090–3094. 21 indexed citations
20.
Linder, Stig, Aleksandra Mandic Havelka, Takayuki Ueno, & Maria C. Shoshan. (2004). Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker. Cancer Letters. 214(1). 1–9. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sung‐Chul Lim Breakdown of academic impact, for papers by Yi‐Hsiung Lin Breakdown of academic impact, for papers by Tomoko Inoue Breakdown of academic impact, for papers by Kageaki Kuribayashi Breakdown of academic impact, for papers by Veerle Van Marck Breakdown of academic impact, for papers by Li-Yuan Bai Breakdown of academic impact, for papers by Gabriella Emri Breakdown of academic impact, for papers by Shouyue Zhang Breakdown of academic impact, for papers by Ying Zheng Breakdown of academic impact, for papers by Chenglong Li
Rankless by CCL
2026